Professor Bruce Mann is a Professor of Surgery at the University of Melbourne and a specialist breast surgeon. He trained in surgery at The Royal Melbourne Hospital, and completed Fellowships at Memorial Hospital in New York and the National Cancer Centre Hospital in Tokyo. He was appointed the Director of the Combined RMH/Women’s Breast Service in 2007, and the Director of the VCCC Beast Tumour Stream in 2016.
His clinical interest relates to all those with suspected or proven early breast cancer, where he was involved in the introduction of sentinel node biopsy to Australia, and more recently the appropriate use of contrast imaging in early breast cancer.
His research interests focus on optimising the early diagnosis and treatment of breast cancer. He is co-chair of the expert advisory group for the ROSA (Roadmap to Optimising Screening in Australia) project of the Cancer Council of Australia. He is the instigator and Principal Investigator of the PROSPECT trial, investigating the role on MRI in the selective omission of radiotherapy in early breast cancer, and the national PI of the UK-led trial of omission of additional axillary treatment in those with limited disease in the sentinel nodes. He led an Australian validation study of the DCISionRT assay in DCIS, and is PI of an Australian registry of this assay.
He is Director of Research for Breast Cancer Trials (Australia and New Zealand’s Breast Cancer Trials group) and on the Board of the Breast Cancer Network of Australia.
2021: BreastSurgANZ Invited lecture. Breast Surgeons of Australia and New Zealand
2017: Woodward Family Medal of Excellence. Royal Women’s Hospital, Melbourne
2010: Gold Marryaylan, Clinical Oncology Society of Australia
2009: British Isles James IV Traveling Fellowship, James IV Association of Surgeons
2008: Premiers Award: Excellence for improving Cancer Care. The Combined Breast Service
2008: Royal Australasian College of Surgeons: Certificate of Outstanding Service